While HIV transmission has been significantly reduced over the past decades — especially among people who inject drugs, who now represent less than 10 percent of new HIV diagnoses per year — the ...

As we enter the next phase of the COVID-19 pandemic, attention is turning to contact tracing. States and cities are gearing up to hire thousands of people to help identify and notify those who may ...

—The Department of Veterans Affairs (VA) is the largest provider of care to patients infected with HIV in the U.S. and is at the forefront of preventing the disease at the national, regional, and ...

But a new commentary by two leading HIV experts at Johns Hopkins argues that despite its disappointing outcome, the Mississippi case and two other recent HIV "rebounds" in adults, have yielded ...

In 2020, global health has gone from a fringe issue to the forefront of people’s mind, all thanks to COVID-19. The last time the entire world came close to being as focused on a pandemic threat was ...

Over 40 years of Black HIV activism changed the nation while proving why Black activists still matter today.

$7.5 million to Battle HIV/AIDS in the United States Earlier this month, President Barack Obama set out a new domestic AIDS policy, which asked cities, states, federal agencies, and the private sector ...

The HIV and AIDS crisis in Africa was—and still is—devastating for the continent’s population. Despite only making up 6.2% of the world’s population, Eastern and Southern Africa is home to 54% of all ...

Federal officials have a favorite refrain about COVID-19: "We have the tools." There's just one problem: As those who have worked to end HIV for decades know, just having the tools is not enough.

The successful results from a clinical trial of a new, long-acting HIV prevention drug are not just a critical milestone for those working on HIV/AIDS, but also for researchers working on other deadly ...

The news in July, 2014 that HIV had returned in a Mississippi toddler after a two-year treatment-free remission dashed the hopes of clinicians, HIV researchers and the public at large tantalized by ...